HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathogenic significance of IgA receptor interactions in IgA nephropathy.

Abstract
IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently progresses to renal failure. The pathogenesis of this disease involves the deposition of undergalactosylated IgA1 complexes in the glomerular mesangium. How the IgA1 complexes are generated and why they are deposited in the mesangium remains unclear. We propose a model wherein two types of IgA receptors participate in sequential steps to promote the development of IgAN, with FcalphaRI (CD89) being initially involved in the formation of circulating IgA-containing complexes and, subsequently, transferrin receptor (CD71) in mediating mesangial deposition of IgA1 complexes.
AuthorsRenato C Monteiro, Ivan C Moura, Pierre Launay, Toshinao Tsuge, Elie Haddad, Marc Benhamou, Max D Cooper, Michelle Arcos-Fajardo
JournalTrends in molecular medicine (Trends Mol Med) Vol. 8 Issue 10 Pg. 464-8 (Oct 2002) ISSN: 1471-4914 [Print] England
PMID12383768 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, B-Lymphocyte
  • CD71 antigen
  • Fc(alpha) receptor
  • Immunoglobulin A
  • Macromolecular Substances
  • Receptors, Fc
  • Receptors, Transferrin
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, B-Lymphocyte (metabolism)
  • Glomerulonephritis, IGA (metabolism)
  • Humans
  • Immunoglobulin A (metabolism)
  • Macromolecular Substances
  • Mice
  • Mice, Transgenic
  • Models, Immunological
  • Receptors, Fc (metabolism)
  • Receptors, Transferrin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: